ArticleOncoTargets and therapy2015

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787.

Aulma R Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.